40
Participants
Start Date
October 30, 2024
Primary Completion Date
May 1, 2025
Study Completion Date
October 1, 2025
Saffranal
HCC patients will receive 50 mg safranal regimen in dose of once per day for six months.
Placebo
HCC patients will receive Placebo in dose of once per day for six months.
Amal A. Elkholy, Al ‘Abbāsīyah
Dermatology Clinic of National Hepatology and Tropical Medicine Research Institute, Cairo
Mohamed, Ahmed A., M.D.
INDIV
Amr Amin College of Medicine, University of Sharjah, Sharjah 27272, UAE.
UNKNOWN
Ahmed Cordie Endemic Medicine department, Cairo University Hospitals.
UNKNOWN
Nouran Mohamed Endemic Medicine department, Cairo University Hospitals.
UNKNOWN
Gamal Esmat Faculty of Biotechnology, Misr University for Science and Technology, Giza, Egypt.
UNKNOWN
Ain Shams University
OTHER